Literature DB >> 7483170

Differentiated thyroid cancer long-term impact of initial therapy.

E L Mazzaferri1, S M Jhiang.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7483170      PMCID： PMC2376543     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  15 in total

1.  Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period.

Authors:  L B WOOLNER; O H BEAHRS; B M BLACK; W M McCONAHEY; F R KEATING
Journal:  Am J Surg       Date:  1961-09       Impact factor: 2.565

2.  Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective.

Authors:  J B Wong; M M Kaplan; K B Meyer; S G Pauker
Journal:  Endocrinol Metab Clin North Am       Date:  1990-09       Impact factor: 4.741

3.  Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients.

Authors:  H R Maxon; E E Englaro; S R Thomas; V S Hertzberg; J D Hinnefeld; L S Chen; H Smith; D Cummings; M D Aden
Journal:  J Nucl Med       Date:  1992-06       Impact factor: 10.057

4.  Treatment of thyroid cancer. Death rates after surgery and after surgery followed by sodium iodide I-131.

Authors:  V M Varma; W H Beierwaltes; M M Nofal; R H Nishiyama; J E Copp
Journal:  JAMA       Date:  1970-11-23       Impact factor: 56.272

5.  The WHO histological classification of thyroid tumors: a commentary on the second edition.

Authors:  C Hedinger; E D Williams; L H Sobin
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

6.  Papillary thyroid carcinoma: the impact of therapy in 576 patients.

Authors:  E L Mazzaferri; R L Young; J E Oertel; W T Kemmerer; C P Page
Journal:  Medicine (Baltimore)       Date:  1977-05       Impact factor: 1.889

Review 7.  Papillary and follicular thyroid cancer: a selective approach to diagnosis and treatment.

Authors:  E L Mazzaferri
Journal:  Annu Rev Med       Date:  1981       Impact factor: 13.739

8.  Pure follicular thyroid carcinoma: impact of therapy in 214 patients.

Authors:  R L Young; E L Mazzaferri; A J Rahe; S G Dorfman
Journal:  J Nucl Med       Date:  1980-08       Impact factor: 10.057

9.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

10.  Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients.

Authors:  E L Mazzaferri; R L Young
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965
View more
  15 in total

Review 1.  The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.

Authors:  M C Skarulis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Controversies and challenges in the management of well-differentiated thyroid cancer.

Authors:  N Gopalakrishna Iyer; Ashok R Shaha
Journal:  Indian J Surg       Date:  2010-01-13       Impact factor: 0.656

Review 3.  Multikinase inhibitors: a new option for the treatment of thyroid cancer.

Authors:  Matti L Gild; Martyn Bullock; Bruce G Robinson; Roderick Clifton-Bligh
Journal:  Nat Rev Endocrinol       Date:  2011-08-23       Impact factor: 43.330

4.  Analysis of medical-decision making and the use of standards of care in oncology.

Authors:  S Holzer; A M Fremgen; S A Hundahl; J Dudeck
Journal:  Proc AMIA Symp       Date:  2000

Review 5.  Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules.

Authors:  Michal Mekel; Carmelo Nucera; Richard A Hodin; Sareh Parangi
Journal:  Am J Surg       Date:  2010-07       Impact factor: 2.565

Review 6.  Total thyroidectomy vs. lobectomy in differentiated thyroid cancer: is there a reasonable size cut-off for decision? A narrative review.

Authors:  Daniele Barbaro; Giancarlo Basili; Gabriele Materazzi
Journal:  Gland Surg       Date:  2021-07

7.  Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation.

Authors:  S Jang; X-M Yu; S Odorico; M Clark; R Jaskula-Sztul; C M Schienebeck; K R Kupcho; A D Harrison; G N Winston-McPherson; W Tang; H Chen
Journal:  Cancer Gene Ther       Date:  2015-08-07       Impact factor: 5.987

8.  A Functional Scoring System Based on Salivary Gland Scintigraphy for Evaluating Salivary Gland Dysfunction Secondary to 131I therapy in Patients with Differentiated Thyroid Carcinoma.

Authors:  Yasuhiro Maruoka; Shingo Baba; Takuro Isoda; Yoshiyuki Kitamura; Koichiro Abe; Masayuki Sasaki; Hiroshi Honda
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 9.  Radiomics in Differentiated Thyroid Cancer and Nodules: Explorations, Application, and Limitations.

Authors:  Yuan Cao; Xiao Zhong; Wei Diao; Jingshi Mu; Yue Cheng; Zhiyun Jia
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

10.  Targeted near infrared hyperthermia combined with immune stimulation for optimized therapeutic efficacy in thyroid cancer treatment.

Authors:  Le Zhou; Mengchao Zhang; Qingfeng Fu; Jingting Li; Hui Sun
Journal:  Oncotarget       Date:  2016-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.